School of Social Work, University of Wisconsin-Madison, 1350 University Ave., Madison, WI 53706, USA.
Child Psychiatry Hum Dev. 2011 Feb;42(1):93-117. doi: 10.1007/s10578-010-0209-y.
This mixed-method study examines (1) the extent to which fifty adolescents receiving wraparound treatment and prescribed psychotropic medication for various psychiatric disorders report that they would continue taking medication if the decision was entirely their own (termed "medication commitment"); (2) their general subjective experiences with medication; and (3) which medication experiences and clinical, social, and demographic factors are associated with greater medication commitment. We found that most adolescents (62%) would discontinue treatment; these "less committed" youth were more likely to report various negative medication perceptions and experiences in open-ended questions, relative to "committed" youth. Multivariate analysis indicated that significant correlates of commitment to medication were: taking antipsychotic medication, greater perceived family support, and lack of perceived coercion to take the medication; clinical or demographic factors were not significantly related to medication commitment. The results reinforce the importance of addressing youths' concerns about medication and maximizing their participation in treatment decision-making.
（1）五十名接受综合治疗并开处精神科药物处方的青少年在多大程度上表示，如果他们自己做决定，他们将继续服药（称为“用药承诺”）；（2）他们对药物治疗的总体主观体验；以及（3）哪些药物体验以及临床、社会和人口统计学因素与更大的用药承诺有关。我们发现，大多数青少年（62%）会停止治疗；这些“不太坚定”的青少年在开放性问题中更有可能报告各种负面的药物认知和体验，而不是“坚定”的青少年。多变量分析表明，与用药承诺相关的显著因素包括：服用抗精神病药物、感知到更多的家庭支持以及没有被感知到的被迫服药的情况；临床或人口统计学因素与用药承诺没有显著关系。研究结果强调了重视青少年对药物的关注和最大限度地参与治疗决策制定的重要性。
